Clinical study at UCI Health will look at Aviptadil as potential COVID-19 treatment

“This study will focus on patients for whom mortality is alarmingly high,” said Dr. Richard Lee, interim chief of UCI Health’s Division of Pulmonary Diseases and Critical Care Medicine and the principal investigator for the clinical trial. “If successful, we hope that treatments such as Aviptadil may change the chances of survival for these patients.”